Patents

  • No. 5,591,629 (January 7, 1997) – "Monoclonal Antibodies which Promote Central Nervous System Remyelination"
  • No. 5,660,828 (August 26, 1997) – "Method of Treating Autoimmune and/or Viral Induced Diseases that are Mediated by CD8 Phenotype T Cells"
  • No. 5,863,529 (January 26, 1999) - "Suppression of Demyelination by Interleukin-6"
  • No. 6,800,285 (October 5, 2004) - "Treatment of Central Nervous System Diseases by Antibodies Against Glatiramer Acetate"
  • European Patent No. 0801679 B1 (March 9, 2005) – "Monoclonal Antibodies which Promote Central Nervous System Remyelination"
  • No. 7,052, 694 (May 30, 2006) – "Dendritic Cell Potentiation"
  • Japanese Patent No. 3789472 (2006) – "Monoclonal Antibodies which Promote Central Nervous System Demyelination"
  • Australian Patent No. 2000261978 (October 19, 2006) – "Human IgM Antibodies with the Capability of Inducing Remyelination, and Diagnostic and Therapeutic Uses Thereof, Particularly in the Central Nervous System"